Corrigendum: Late-stage MC38 tumours recapitulate features of human colorectal cancer - implications for appropriate timepoint selection in preclinical studies.
Autor: | Shields NJ; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand., Peyroux EM; Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand., Ferguson AL; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Liver Injury and Cancer Program, Centenary Institute, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Steain M; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Neumann S; Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand., Young SL; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Faculty of Science, University of Canterbury, Christchurch, New Zealand. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in immunology [Front Immunol] 2024 Jun 11; Vol. 15, pp. 1430460. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024). |
DOI: | 10.3389/fimmu.2024.1430460 |
Abstrakt: | [This corrects the article DOI: 10.3389/fimmu.2023.1152035.]. (Copyright © 2024 Shields, Peyroux, Ferguson, Steain, Neumann and Young.) |
Databáze: | MEDLINE |
Externí odkaz: |